Hyperthermic preconditioning protects against spinal cord ischemic injury.
Ann. Thorac. Surg., Nov;70(5):1490-5 (2000)
Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
Transplant. Proc., Feb;25(1 Pt 2):1225-6 (1993)
Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
J. Immunol., Jun;148(12):3746-52 (1992)
The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells.
Transplantation., May;53(5):1063-70 (1992)
Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
Bone Marrow Transplant., Mar;9(3):191-7 (1992)
Mechanism of the anti-GVHD effect of IL-2. I. Protective host-type cell populations are not induced by IL-2 treatment alone.
Bone Marrow Transplant., 7 Suppl 1:29-32 (1991)
Operative treatment of Crohn's ileocolitis complicated by ileosigmoid and ileovesical fistulae.
Ann. Surg., Jan;207(1):48-51 (1988)
Comparative evaluation of antiperistaltic exit conduits, autologous smooth muscle wraps, and nipple valves for ileostomy continence.
Curr Surg., 43(3):211-3 (1986 May-Jun)
Portal versus caval venous drainage of small bowel allografts: technical and metabolic consequences.
Surgery., Feb;99(2):193-8 (1986)
Portal versus systemic venous drainage for small-bowel allografts.
Surgery., Sep;98(3):579-86 (1985)